Expanding Ketamine Application for Treatment of Acute Suicidality in Long-Duration Spaceflight
Introduction. The transition to exploration missions places a heightened risk on behavioral health in spaceflight. Although serious psychiatric emergencies during spaceflight have been rare, longer duration missions increase the possibility of emergence in latent mental health di
Selection note: Curated because this 2024 preprint (draft being sent to journal) from Aerospace Medical Association specifically covers “Expanding Ketamine Application for Treatment of Acute Suicidality in Long-Duration Spaceflight”; its abstract describes Introduction. The transition to exploration missions places a heightened risk on behavioral health in spaceflight. Although serious psychiatric emergencies during… This materially informs GShips health and autonomous medicine.
Evidence boundary: NTRS lists open full text, but this pass assessed catalog metadata and abstract rather than independently validating the document. Inclusion is contextual discovery support, not automatic evidence for a GShips claim.
Stable record
ntrs-20240012115
Topic
health-medicine
Type
Preprint (Draft being sent to journal)
Publisher
Aerospace Medical Association
Authors
Craig J Kutz; Amit M Mistry; Charles H Dukes
Year
2024
Editorial state
metadata curated editorial draft
Reviewer
GShips Project editorial synthesis
Official link checked
2026-07-25
Source-supplied abstract
Introduction. The transition to exploration missions places a heightened risk on behavioral health in spaceflight. Although serious psychiatric emergencies during spaceflight have been rare, longer duration missions increase the possibility of emergence in latent mental health disorders due to genetic predisposition, increased autonomy, isolation, helplessness, loss of family member, or catastrophic events. Complicated grief and bereavement have the highest rate of suicidal ideation. Recently, ketamine has been used as an emergent intervention for acute suicidality, promoting its stability, ease of administration, favorable safety profile, and outcomes for reduction of suicidal intent. The goal of this study was to review current literature and collate the understanding of ketamine as a safe, effective pharmacological adjunct for acute suicidality in spaceflight.
Methods. This literature review was conducted to collate data on ketamine use for acute suicidality and inform on stability, limitations and utilization of ketamine within extreme environments.
Results. 122 publications were reviewed for relevance including 23 randomized-control trials for ketamine use in behavioral emergencies.
Discussion. Ketamine is a diverse pharmaceutical with multiple advantageous indications, including acute suicidality, pain, and sedation. Terrestrial use of ketamine suggests a rapidly efficacious medication for reduction in acute suicidality. As behavioral stressors expand related to extended missions, contingencies for behavioral emergencies become increasingly important. Although this review is not intended to re-develop current International Space Station (ISS) protocols, it is the first to discuss the benefits of ketamine in spaceflight as a potential safe, effective multifaceted tool for future exploration missions and treatment for acute suicidal ideation.
Abstract text has not been adopted as a GShips conclusion.
What would change this record?
A newer or corrected version, a retraction, a verified duplicate, a material topic mismatch, a changed access state, or claim-level review would trigger a dated editorial update.
NTRS lists open full text, but this pass assessed catalog metadata and abstract rather than independently validating the document. Inclusion is contextual discovery support, not automatic evidence for a GShips claim.
Source-supplied titles, abstracts, authors, and dates may require correction against the canonical full text.
What would change this page?
A newer or corrected version, retraction, verified duplicate, material topic mismatch, changed access state, or claim-level assessment would change this record.
People, review, and conflicts
Prepared by
GShips Project
Editorial status
metadata-curated-editorial-draft
Editorial reviewer
GShips Project editorial synthesis
Last editorial review
No editorial-review date recorded
Independent review
pending
Independent reviewer
No independent reviewer assigned
Last independent review
No independent-review date exists
Last content edit
Not recorded separately
Official source or link verified
2026-07-25
Declared conflicts
The maintainer intends to explore a commercial venture based on some GShips work. No entity, outside funding, customer, sponsor, or indexed-organization relationship currently exists.